Phase I Single-blind Clinical Trial to Evaluate the Safety and Local Immune Activation of a Toll-like Receptor 5 Agonist (FLAMOD) Administered by Aerosol
Clinical trial NCT06681402 · COMPLETED
Trial details
- NCT number
- NCT06681402
- Sponsor
- Institut National de la Santé Et de la Recherche Médicale, France
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2025-04-14
- Primary completion
- 2026-04-17
- Enrollment
- 46
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.